| Literature DB >> 33802734 |
Giuseppe Martucciello1,2, Federica Fati1,2, Stefano Avanzini2, Filippo Maria Senes3, Irene Paraboschi1,2.
Abstract
Cervicothoracic neuroblastomas (NBs) pose unique surgical challenges due to the complexity of the neurovascular structures located in the thoracic inlet. To date, two main techniques have been reported to completely remove these tumours in children: the trans-manubrial and the trap-door approaches. Herein, the authors propose a third new surgical approach that allows a complete exposure of the posterior costovertebral space starting from the retro-clavicular space: Cervico-Parasternal Thoracotomy (CPT). The incision is made along the anterior margin of the sternocleidomastoid muscle until its sternal insertion, and then the incision proceeds vertically following the ipsilateral parasternal line. The major pectoralis muscle is detached, and the clavicle and the ribs are disarticulated from their sternal insertions. Following an accurate isolation of the major subclavian blood vessels and the brachial plexus roots, the tumour is then completely exposed and resected by switching from a frontal to a lateral view of the costo-vertebral space. By adopting this technique, five cervicothoracic NBs were completely resected in a median operative time of 370 min (range: 230-480 min). By proceeding in safety with the heart apart, neither vascular injuries nor nerve damages occurred, and all patients were safely discharged in a median postoperative time of 11 days (range: 7-14 days). At the last follow-up visit (median: 16 months, range: 13-21 months), all patients were alive and disease-free.Entities:
Keywords: cervical tumours; mediastinal tumours; neuroblastoma; thoracotomy
Year: 2021 PMID: 33802734 PMCID: PMC8002489 DOI: 10.3390/children8030229
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1MRI scans of a patient affected by a cervicothoracic NB treated with CPT type B. The tumour causes the antero-lateral dislocation of the internal jugular vein, the right carotid artery, the trachea, and the bronchial biforcation. Posteriorly it penetrates into the epidural space (T1–T3), without compressing it. Inferiorly it extends toward the interscalen space along the brachial plexus. The subclavian and vertebral artery are in strict contact but not infiltrated by the tumour.
Figure 2Main surgical approaches for the resection of cervicothoracic NBs. The red line shows the site of the surgical incision. (A). The Trans-Manubrial Sternotomy (TMS). (B). The Trap-Door Approach (TDA). (C). Cervico-Parasternal Thoracotomy (CPT) type A. (D). Cervico-Parasternal Thoracotomy (CPT) type B.
Figure 3Main steps of the Cervico-Parasternal Thoracotomy (CPT). (A). Incision line for CPT type A. (B,C). Surgical dissection of the subcutaneous tissue. (D,E). Detachment of the major pectoralis muscle and identification and disarticulation of the clavicle and the ribs from their sternal insertion. (F). Identification and isolation of vital structures: common carotid artery (red elastic wire), subclavian artery (red elastic wire), internal jugular vein (blue elastic wire), phrenic nerve (white elastic wire). (G–I). Main steps and incision line for CPT type B.
Patient demographic and tumour findings.
| PATIENT 1 | PATIENT 2 | PATIENT 3 | PATIENT 4 | PATIENT 5 | |
|---|---|---|---|---|---|
| Age at surgery (years) | 11 | 9 | 2 | 2 | 7 |
| Gender | male | female | female | male | male |
| Site | right | right | right | right | right |
| ASA status | 2 | 3 | 3 | 3 | 3 |
| IN Staging System | III | III | III | III | IV |
| INRG Staging System | L2 | L2 | L2 | L2 | M |
| MYCN status | not amplified | not amplified | not amplified | not amplified | amplified |
| Histology | favourable | favourable | favourable | favourable | unfavourable |
| Previous surgery | no | yes | no | no | yes |
| Operative time (min) | 240 | 480 | 480 | 370 | 230 |
| RBC transfusion | no | yes | yes | no | yes |
| Hospital stay (days) | 10 | 13 | 14 | 11 | 7 |
| ICU stay (hours) | 24 | 48 | 72 | 96 | 24 |
| Preoperative chemotherapy | no | yes | yes | yes | yes |
| Postoperative therapy | no | no | cis-retinoic acid) | radiotherapy | cis-retinoic acid & immunotherapy comprising anti-GD2 antibody (ch14.18) and IL-2 |
| Postoperative complications | no | no | no | no | no |
| Follow up (months) | 21 | 18 | 13 | 15 | 17 |
| Follow up status | alive, | alive, | alive, | alive, | alive, |
Main articles reporting the surgical experience with cervicothoracic neuroblastomas in children.
| AUTHORS | PATIENTS’ POPULATION | AGE (Average, Range; Months) | SURGICAL APPROACH | OPERATIVE TIME (Average, Range; | TUMOUR | HOSPITAL STAY (Average, Range; Days) | COMPLICATIONS | SURVIVAL OUTCOMES | FOLLOW-UP PERIOD (Average, Range; Months) |
|---|---|---|---|---|---|---|---|---|---|
| Pranikoff T et al., 1995 [ | 2 | 10.5 (4–17) | Trap-door ( | nd | Ganglioneuroblastoma ( | 7.5 (5–10) | None | nd | nd |
| Sauvat F et al., 2006 [ | 4 | 35 (10–84) | Trans-manubrial ( | nd | Neuroblastoma ( | nd | Chylotorax ( | Alive: 4/4 (100.0%); complete remission: 4/4 (100.0%) | nd (8–32) |
| Pimpalwar AP et al., 2007 [ | 1 | 24 (na) | Trans-manubrial ( | 160 | Ganglioneuroblastoma ( | 2 | Bernard–Horner Syndrome ( | Alive: 1/1 (100.0%); complete remission: 1/1 (100.0%) | 6 (na) |
| Jones vs. et al., 2008 [ | 1 | 42 (na) | Trap-door ( | nd | Ganglioneuroma ( | nd | Bernard–Horner Syndrome ( | Alive: 1/1 (100.0%); complete remission: 1/1 (100.0%) | 3 (na) |
| Parikh D et al., 2011 [ | 3 | 24 (nd) | Trap-door ( | nd | Neuroblastoma ( | nd | nd | Alive: 2/3 (66.7%); complete remission: 2/3 (66.7%) | 57.3 (16–96) |
| De Corti et al., 2012 [ | 8 | 45.6 (nd) | Trans-manubrial ( | 263.8 (140–410) | Neuroblastoma ( | 11.9 (9–26) | Chylotorax ( | Alive: 8/8 (100.0%); complete remission: 7/8 (87.5%) | 24 |
| McMahon et al., 2013 [ | 1 | 48 (na) | Trap-door ( | nd | Ganglioneuroblastoma ( | nd | Bernard–Horner Syndrome | Alive: 1/1 (100.0%); complete remission: 1/1 (100.0%) | 60 |
| Qureshi SS et al., 2014 [ | 7 | 36 (11–72) | Trans-manubrial ( | 327 (69–240) | Neuroblastoma ( | 6.5 (5–10) | Diaphragmatic paralysis ( | Alive: 5/7 (66.7%); complete remission: 5/7 (66.7%) | nd |
| El Madi A et al., 2007 [ | 9 | 71.8 (4–188) | Trans-manubrial ( | nd | Neuroblastoma ( | 7 | Chylothorax ( | Alive: 7/9 (77.8%); complete remission: 4/9 (44.4%) | 92.6 (3–190) |
| Chui CH et al., 2020 [ | 21 | 42 (3.6–94.8) | Trap-door ( | 312 (150–546) | Neuroblastoma ( | nd | Klumpke’s palsy ( | Alive: 16/21 (75.0%); complete remission: nd | 33.6 (3.6–92.4) |
Abbr. na: not applicable, nd: not determined.